Sector
988 stories · page 31 of 50
“The team at KGK has been busy to start 2022 and I would like to commend them on their successes this year to date," said Wellbeing CEO Najla Guthrie
The company called the deal the next step in the execution of its ketamine clinic roll-up strategy, telling shareholders that the move is part of its plan to become the world’s largest chain of psychedelic mental health clinics
The strategy, engineered by its recently appointed CEO, Najla Guthrie, will seek to establish next-generation mental health clinics, contemporize existing clinic facilities and launch best-in-class adjunct programs to improve patient treatm
HealthHub connects, manages, and monitors both standardized medical and non-medical devices for a completely integrated IoMT and IoT intelligent edge solution
The US class action against the company and certain of its former officers was filed in the United States District Court for the Central District of California in April, 2021, while the Canadian Class Action was filed in the British Columbi
"Novartis are proud to partner with HealthBeacon on this project," said Audrey Derveloy, Country President of Novartis in Ireland
The company said a head-to-head drug elution study of its three undisclosed DMT-analogue candidates has now been completed while supportive cell-based biocompatibility has been examined
Guthrie, who has been the president and CEO of Wellbeing’s wholly-owned subsidiary KGK Science Inc since 1997, has been appointed to lead the development of an evolved competitive strategy
The company said Hvizd is expected to be instrumental in acquiring strategic partnerships and accelerating sustainable revenue growth
HealthBeacon is expecting revenues to grow ten-fold by the end of next year
Drug-resistant infections will cause the death of an estimated 10mln people per year across the globe by 2050
The company intends to expand treatment options at its clinics by offering a broad portfolio of powerful next-generation therapies, including the psychedelic ketamine
The 12-week, randomized, double-blinded and placebo-controlled clinical trial included a sample of 206 overweight and obese adults from four different locations in the US and Canada
“Peyote and mescaline in general are currently underrepresented in the psychedelic medicine sector, given their traditional medicinal uses," said Najla Guthrie, president and CEO of KGK
The company said it has acquired 15 ketamine-enhanced mental wellness treatment clinics across North America with letters of intent signed for an additional clinic
Midwest Ketafusion, a profitable ketamine clinic with a strong track record, will be rebranded as ‘Emergence by Irwin Naturals
“We sell nutraceuticals to some of the biggest publicly traded retailers, we've been around 28 years, and we're a household name,” the company's CEO Klee Irwin told Proactive
It is understood the group has submitted its prospectus to the London Stock Exchange ahead of a float in late spring
Guthrie is the current Chief Research Officer and president of KGK Science Inc and has led it to become a leading North American contract research organization that primarily provides high-quality clinical research trials with a focus on th
